Thursday, September 8, 2016

BRIEF-Clovis Oncology -FDA has notified it is not currently planning to hold advisory committee meeting to discuss for Rucaparib

* FDA has notified co that FDA is not currently planning to

hold advisory committee meeting to discuss NDA for Rucaparib

Source text: [http://bit.ly/2c9EYtK]

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)